En Es
Categories

CHEMBIO DIAGNOSTIC SYSTEMS

CHEMBIO DIAGNOSTIC SYSTEMS

Chembio develops, manufactures and commercializes diagnostic solutions and products for the rapid and early detection of HIV and syphilis at the point of care. It has products on the market in over 40 countries and seeks to develop new products to enable early and improved treatment of malaria, Ebola, febrile illness ...
Products Covid-19NewsSummary
Close

Covid-19 CHEMBIO DIAGNOSTIC SYSTEMS

Clinical Laboratory

Digital Reader
DPP Micro Reader

The DPP Micro Reader is a handheld device that enables testing for SARS-CoV-2 and other DPP tests. The maintenance free reader streamlines the point-of-care testing experience with precise and accurate results, minimizing human errors due to visual interpretation.
More details

Digital Reader
DPP Micro Reader II

The DPP Micro Reader II is a handheld device that enables testing for SARS-CoV-2 and streamlines the point-of-care testing experience with precise and accurate results. The maintenance free reader delivers automated results in 15-20 seconds and minimizes human errors due to visual interpretation.
More details

COVID-19 IgM/IgG Test
DPP COVID-19 IgM/IgG System

The DPP COVID-19 IgM/IgG System is an ANVISA Approved rapid test for the detection and differentiation of IgM and IgG antibodies to SARS-CoV-2 in capillary “fingerstick” whole blood, venous whole blood, serum and plasma samples. A simple to use, handheld, portable DPP Micro Reader provides simultaneous and separate detection of IgM and IgG antibodies to SARS-CoV-2 in 15 minutes using a small sample size of only 10 μL.
More details
Close

News of CHEMBIO DIAGNOSTIC SYSTEMS

Chembio Diagnostics Announces Two New Senior-Level Appointments

25 Oct 2016
Chembio Diagnostics Announces Two New Senior-Level Appointments
Chembio Diagnostics, Inc., which develops, manufactures, licenses and markets rapid point-of-care (POC) diagnostic tests for infectious diseases, has made two new senior-level appointments.
Read More
Close

About CHEMBIO DIAGNOSTIC SYSTEMS

Chembio develops, manufactures and commercializes diagnostic solutions and products for the rapid and early detection of HIV and syphilis at the point of care. It has products on the market in over 40 countries and seeks to develop new products to enable early and improved treatment of malaria, Ebola, febrile illness, dengue fever and influenza.

Recently updated

COVID-19 IgM/IgG Test
DPP COVID-19 IgM/IgG System

The DPP COVID-19 IgM/IgG System is an ANVISA Approved rapid test for the detection and differentiation of IgM and IgG antibodies to SARS-CoV-2 in capillary “fingerstick” whole blood, venous whole blood, serum and plasma samples. A simple to use, handheld, portable DPP Micro Reader provides simultaneous and separate detection of IgM and IgG antibodies to SARS-CoV-2 in 15 minutes using a small sample size of only 10 μL.
More details

Digital Reader
DPP Micro Reader II

The DPP Micro Reader II is a handheld device that enables testing for SARS-CoV-2 and streamlines the point-of-care testing experience with precise and accurate results. The maintenance free reader delivers automated results in 15-20 seconds and minimizes human errors due to visual interpretation.
More details

Digital Reader
DPP Micro Reader

The DPP Micro Reader is a handheld device that enables testing for SARS-CoV-2 and other DPP tests. The maintenance free reader streamlines the point-of-care testing experience with precise and accurate results, minimizing human errors due to visual interpretation.
More details

Clinical Laboratory

COVID-19 IgM/IgG Test
DPP COVID-19 IgM/IgG System

The DPP COVID-19 IgM/IgG System is an ANVISA Approved rapid test for the detection and differentiation of IgM and IgG antibodies to SARS-CoV-2 in capillary “fingerstick” whole blood, venous whole blood, serum and plasma samples. A simple to use, handheld, portable DPP Micro Reader provides simultaneous and separate detection of IgM and IgG antibodies to SARS-CoV-2 in 15 minutes using a small sample size of only 10 μL.
More details

Digital Reader
DPP Micro Reader II

The DPP Micro Reader II is a handheld device that enables testing for SARS-CoV-2 and streamlines the point-of-care testing experience with precise and accurate results. The maintenance free reader delivers automated results in 15-20 seconds and minimizes human errors due to visual interpretation.
More details

Digital Reader
DPP Micro Reader

The DPP Micro Reader is a handheld device that enables testing for SARS-CoV-2 and other DPP tests. The maintenance free reader streamlines the point-of-care testing experience with precise and accurate results, minimizing human errors due to visual interpretation.
More details

HIV Test
HIV 1/2 STAT-PAK DIPSTICK Assay

The HIV 1/2 STAT-PAK DIPSTICK tests are easy-to-perform, single-use diagnostic tests for the rapid, visual detection of antibodies to HIV 1 and HIV 2. It requires a minimal sample size of 5 µL and is ideally suited for field and point-of-care testing.
More details

HIV Test
STAT-VIEW HIV 1/2 Assay

The STAT-VIEW HIV 1/2 Assay is a unique, easy-to-use, self-contained, single-use collection and testing device for the rapid, visual detection of antibodies to HIV 1 and HIV. It requires a minimal sample size of 2.5 µL and is ideally suited for field and point-of-care testing.
More details

T. cruzi. Test
Chagas STAT-PAK Assay

The Chagas STAT-PAK Assay is easy to perform, requires no cold chain storage, uses a minimal sample size, and provides visual detection of antibodies to T. cruzi. It requires a minimal sample size of 10 µL whole blood, 5 µL serum or plasma and is ideally suited for field and point-of-care testing.
More details

HIV 1/2 Test
SURE CHECK HIV 1/2 Assay

The SURE CHECK HIV 1/2 Assay is a unique, easy-to-use, self-contained, single-use collection and testing device for the rapid, visual detection of antibodies to HIV 1 and HIV 2. It provides results in 15 minutes from serum, plasma, fingerstick and venipuncture whole blood.
More details

HIV 1/2 Test
DPP HIV 1/2 Assay

The DPP HIV 1/2 Assay is a CLIA-waived test for the rapid detection of HIV 1 and HIV 2 antibodies in oral fluid and all blood matrices. It is intended for use as a POC test to aid in the diagnosis of infection with HIV 1 and HIV 2 and is suitable for use in multi-test algorithms that have been established in many countries or as a standalone initial test.
More details

Syphilis Test
DPP Syphilis Screen & Confirm Assay

The DPP Syphilis Screen & Confirm Assay is a rapid POC test that simultaneously and separately detects treponemal and nontreponemal antibodies. It provides results in as little as 15 minutes, enabling physicians to make treatment decisions, while reducing overtreatment rate and cost burden by eliminating repeated visits to healthcare professionals.
More details

DPP Zika IgM/IgG System
DPP Zika IgM/IgG System

The DPP Zika IgM/IgG System comprises single-use point-of-care (POC) assays for use with a reader for the discrete, semi-quantitative detection of Immunoglobulin M (IgM) and Immunoglobulin G (IgG) antibodies to Zika Virus. It uses ready-to-use reagents (no special preparation of reagents required) and a simple procedure to deliver rapid results in 15 minutes.
More details

Rapid Test System
DPP Zika IgM System

The DPP Zika IgM System is a 15 minute rapid test for detecting Zika virus IgM antibodies in fingerstick whole blood, EDTA venous whole blood, EDTA plasma and serum. The easy to use handheld digital reader provides objective results and detects Zika virus IgM antibodies from 8 days up to 12 weeks.
More details

HIV-Syphilis Assay Test
DPP HIV-Syphilis Assay

The DPP HIV-Syphilis Assay is a single-use, immunochromatographic, rapid test for the detection of antibodies to Human Immunodeficiency Virus Types 1 and 2 (HIV 1/2) and Treponema pallidum (the causative agent of syphilis) in fingerstick whole blood, venous whole blood, serum, and plasma. It is intended for use as a point-of-care test to aid in the diagnosis of infection with HIV and/or Syphilis, and is suitable for use in multi-test algorithms designed for the statistical validation of rapid HIV test results.
More details
Copyright © 2000-2021 TradeMed.com. All rights reserved. | Terms And Conditions